-
921
The Microlensing Event Rate and Optical Depth from MOA-II 9 Yr Survey Toward the Galactic Bulge
Published 2025-01-01Get full text
Article -
922
A Primary Pulmonary Glomus Tumor: A Case Report and Review of the Literature
Published 2012-01-01Get full text
Article -
923
-
924
-
925
-
926
-
927
-
928
-
929
-
930
-
931
Endometrial Cancer and Hypermethylation: Regulation of DNA and MicroRNA by Epigenetics
Published 2012-01-01Get full text
Article -
932
A novel frameshift variant of GATA3 (p.Ala17ProfsTer178) responsible for HDR syndrome in a Japanese family
Published 2024-11-01Get full text
Article -
933
-
934
RAS/RAF/MEK/ERK and PI3K/PTEN/AKT Signaling in Malignant Melanoma Progression and Therapy
Published 2012-01-01Get full text
Article -
935
-
936
Management of thyroid tumors diagnosed cytologically as follicular neoplasms in a high-volume center: utility of a scoring system using serum thyroglobulin level, tumor size, ultra...
Published 2025-02-01“…Gene panel testing was recently introduced to determine the management strategy for FN; however, it is unavailable in Japan. In this study, we assessed FN management. …”
Get full text
Article -
937
A Case of Nonfunctioning Pituitary Carcinoma That Responded to Temozolomide Treatment
Published 2012-01-01Get full text
Article -
938
AOZORA: long-term safety and joint health in paediatric persons with haemophilia A without factor VIII inhibitors receiving emicizumab – protocol for a multicentre, open-label, pha...
Published 2022-06-01“…The AOZORA study will evaluate the long-term safety and joint health of paediatric PwHA without factor (F)VIII inhibitors taking emicizumab; here, we report the details of the study protocol and baseline data.Methods and analysis AOZORA is a multicentre, open-label, phase IV clinical study in Japan that aims to enrol approximately 30 PwHA aged <12 years without FVIII inhibitors. …”
Get full text
Article -
939
Immunostimulatory Effects of Guanine-Quadruplex Topologies as Scaffolds for CpG Oligodeoxynucleotides
Published 2025-01-01Get full text
Article -
940
Targeting KRAS‐mutant pancreatic cancer through simultaneous inhibition of KRAS, MEK, and JAK2
Published 2025-02-01Get full text
Article